Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage

Ai zheng = Aizheng = Chinese journal of cancer

Volumn 25, Issue 12, 2006, Pages 1543-1549

  Zou, Guo Rong ^a   Zhang, Yu Jing ^a   Xie, Fang Yun ^a   Zheng, Wei ^a   Li, Hui Xin ^a   Xia, Yun Fei ^a   Lin, Tong Yu ^a   Lu, Tai Xiang ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHOP PROTOCOL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MALE; MEGAVOLTAGE RADIOTHERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, EXTRANODAL NK-T-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, HIGH-ENERGY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; VINCRISTINE; YOUNG ADULT;

EID: 61849137967     PISSN: 1000467X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)